1150618-22-6 Usage
General Description
4-hydroxyquinoline-7-carboxylic acid, also known as 4-HQC, is a chemical compound belonging to the class of quinolone derivatives. It is a hydroxy derivative of quinoline-7-carboxylic acid and is widely used in the pharmaceutical industry for its antibacterial, antifungal, and antiviral properties. 4-HQC has been studied for its potential as an antimicrobial agent and has shown promise in inhibiting the growth of various pathogenic microorganisms. It has also been investigated for its potential use in the treatment of bacterial infections, particularly those caused by resistant strains. Additionally, 4-HQC has been researched for its potential as an antitumor agent due to its ability to inhibit the growth of cancer cells. Overall, 4-hydroxyquinoline-7-carboxylic acid is a versatile and potentially valuable chemical with diverse applications in medicine and biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 1150618-22-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,0,6,1 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1150618-22:
(9*1)+(8*1)+(7*5)+(6*0)+(5*6)+(4*1)+(3*8)+(2*2)+(1*2)=116
116 % 10 = 6
So 1150618-22-6 is a valid CAS Registry Number.
1150618-22-6Relevant articles and documents
TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS
-
, (2013/02/28)
Compounds of Formula (I) are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula (I) have a structure where the definitions of the variables are provided herein.
QUINOLINE DERIVATIVES
-
Page/Page column 176, (2008/06/13)
The invention concerns quinoline derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
